Skip to main content
. 2020 Jun 4;16:1399–1410. doi: 10.2147/NDT.S241142

Figure 1.

Figure 1

Relative viability of BV-2 cells under different treatments. BV-2 cells were treated with gradient concentration of Aβ (A) and MeJA (B) for 48 hr. (C) BV-2 cells were treated with 20 μM of MeJA and/or 20 μM Aβ or not.